New anti-HSV therapeutics target the helicase–primase complex
- 1 April 2002
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 8 (4) , 327-328
- https://doi.org/10.1038/nm0402-327
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex diseaseNature Medicine, 2002
- Herpes simplex virus helicase-primase inhibitors are active in animal models of human diseaseNature Medicine, 2002
- HERPES SIMPLEX VIRUS DNA REPLICATIONAnnual Review of Biochemistry, 1997
- Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphataseJournal of Virology, 1992
- A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- Herpes simplex virus-1 helicase-primasePublished by Elsevier ,1991
- Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.Proceedings of the National Academy of Sciences, 1980
- Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1.Proceedings of the National Academy of Sciences, 1980
- Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphateJournal of Virology, 1979
- Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanineProceedings of the National Academy of Sciences, 1977